Wealth Alliance Iovance Biotherapeutics, Inc. Transaction History

Wealth Alliance

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 18, 2021	SELL	$28.67 - $52.59 $126,148 - $231,396	-4,400 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$28.04 - $50.26 $56,080 - $100,520	-2,000 Reduced 31.25%	4,400 $204,000
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $55,500 - $72,600	-2,000 Reduced 23.81%	6,400 $211,000
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $228,564 - $344,400	8,400 New	8,400 $231,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.